This inventor holds 1 USPTO granted patent. Top assignee: Beijing Kimway Biotech Co. Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chenfeng Mao: Innovator in Anti-Atherosclerosis Research
Introduction
Chenfeng Mao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical research, particularly in the area of anti-atherosclerosis. His innovative work has the potential to impact the treatment of related diseases.
Latest Patents
Chenfeng Mao holds a patent for "Immunogenic Peptide Fragments of Metalloprotease ADAMTS-7 and Uses Thereof in Anti-Atherosclerosis and Related Diseases." This patent highlights his focus on developing therapeutic solutions aimed at combating atherosclerosis.
Career Highlights
Mao is associated with Beijing Kimway Biotech Co. Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a deep understanding of the underlying biological mechanisms involved in cardiovascular diseases.
Collaborations
Throughout his career, Chenfeng has collaborated with notable colleagues, including Wei Kong and Yi Fu. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Beijing Kimway Biotech Co. Ltd.
Conclusion
Chenfeng Mao's contributions to the field of anti-atherosclerosis research exemplify the impact of innovative thinking in medicine. His patent and ongoing work at Beijing Kimway Biotech Co. Ltd. position him as a key figure in the fight against cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile